Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03401489 · ClinicalTrials.gov registry record · NA
PACESETTER: Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor
A NA study, sponsored by Northern California Institute of Research and Education.
- Terminated
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT03401489 is a NA study that was terminated before completion, run by Northern California Institute of Research and Education. The registered enrollment target is 120 participants.
The verdict
NCT03401489, a NA study, was terminated before completion, sponsored by Northern California Institute of Research and Education.
- TERMINATED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
Program to Avoid Cerebrovascular Events through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor (PACESETTER) aims to assess the incorporation of its stroke intervention into 2 safety net/academic health systems in a given US state especially burdened by stroke, thereby enhancing knowledge about the complexity of stroke interventions, and especially the nature of the challenges encountered in low resource settings and for populations traditionally underrepresented in research. Altogether, the intervention, if proven implementable and effective, may eventually be exported to other medically underserved populations in the US beyond SC as a feasible model of post-stroke management.
Interventions
- DEVICE PACESETTER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2020-07-14 |
| Est. Completion | 2024-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03401489
The ClinicalTrials.gov registry entry for NCT03401489 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northern California Institute of Research and Education, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PACESETTER is the first listed.
NCT03401489 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03401489 about?
NCT03401489 is a clinical study titled "PACESETTER: Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor". Program to Avoid Cerebrovascular Events through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor (PACESETTER) aims to assess the incorporation of its stroke intervention into 2 safety net/academic health systems in a given US state especially burdened by stroke, thereby enhanci...
What is the current status of trial NCT03401489?
This trial is currently terminated. It is a NA study. The enrollment target is 120 participants. The study started on 2020-07-14. Estimated completion is 2024-02-28.
What interventions are being tested in trial NCT03401489?
The interventions under investigation include: PACESETTER (DEVICE).
Who is sponsoring clinical trial NCT03401489?
This trial is sponsored by Northern California Institute of Research and Education, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.